Lazari Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
6,179
+58
+0.9% +$13.5K 0.48% 36
2026
Q1
$1.5M Sell
6,121
-13
-0.2% -$3.03K 0.52% 37
2025
Q4
$1.27M Sell
6,134
-121
-2% -$23.9K 0.43% 42
2025
Q3
$1.16M Buy
6,255
+117
+2% +$20K 0.39% 45
2025
Q2
$938K Buy
6,138
+22
+0.4% +$3.38K 0.35% 49
2025
Q1
$1.01M Sell
6,116
-161
-3% -$25.2K 0.41% 46
2024
Q4
$908K Buy
6,277
+260
+4% +$40.3K 0.36% 43
2024
Q3
$975K Buy
6,017
+32
+0.5% +$5.1K 0.42% 42
2024
Q2
$875K Buy
5,985
+387
+7% +$57.6K 0.39% 44
2024
Q1
$886K Sell
5,598
-88
-2% -$14K 0.48% 35
2023
Q4
$891K Buy
5,686
+19
+0.3% +$2.91K 0.51% 34
2023
Q3
$883K Sell
5,667
-1,988
-26% -$328K 0.53% 35
2023
Q2
$1.27M Buy
+7,655
New +$1.24M 0.71% 26

Other funds holding JNJ

Lazari Capital Management's JNJ Position: Q2 2026 in Review

Lazari Capital Management increased its Johnson & Johnson (JNJ) stake by 0.95% in Q2 2026, buying an estimated $13.5K and bringing the position to 6,179 shares worth $1.57M. The position accounts for 0.48% of the portfolio, ranked #36.

Lazari Capital Management first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lazari Capital Management held 6,179 shares of Johnson & Johnson worth $1.57M as of Q2 2026.
  • Lazari Capital Management bought 58 Johnson & Johnson shares in Q2 2026, an estimated $13.5K.
  • Johnson & Johnson made up 0.48% of Lazari Capital Management's portfolio in Q2 2026, its #36 holding.
  • Lazari Capital Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.